5 innovadores medicamentos chinos, incluyendo inhibidores de:
🧬 KRAS G12C
🧬 EGFR de tercera generación
🧬 EGFR exon 20

#Fulzerasib #Sunvozertinib #Limertinib #Glecirasib #Garsorasib #Cáncer #Oncología #TerapiaDirigida #InnovaciónMédica #KRAS
#KRASG12C #EGFR #EGFRexon20 #DengYueMedicinasEnHongKong

Innovent's Limertinib Approved for First-Line Lung Cancer Treatment by NMPA Innovent Biologics announces NMPA approval for Limertinib, a pioneering treatment for lung cancer, marking a significant advancement in patient care.

Innovent's Limertinib Approved for First-Line Lung Cancer Treatment by NMPA #China #Suzhou #Lung_Cancer #Innovent #Limertinib